When evaluating a patient who is taking orlistat, which is an intended therapeutic effect?
Decreased weight
Increased appetite
Decreased hyperactivity
Increased wakefulness
The Correct Answer is A
A. Decreased weight: Orlistat is a medication used for weight management by inhibiting the absorption of dietary fats. Its intended therapeutic effect is to promote weight loss by reducing the amount of fat absorbed from the diet.
B. Increased appetite: Orlistat does not increase appetite; rather, it may help control appetite by promoting satiety through its mechanism of action.
C. Decreased hyperactivity: Orlistat is not indicated for the treatment of hyperactivity.
D. Increased wakefulness: Orlistat does not affect wakefulness; it primarily acts in the gastrointestinal tract to inhibit fat absorption.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is ["A","B","D"]
Explanation
A. Constipation is a common adverse effect of opioid medications, including hydrocodone.
Opioids can slow down bowel motility, leading to constipation.
B. Lightheadedness is a common side effect of opioids, particularly when a patient first starts
taking them or when the dose is increased. It can be due to the central nervous system depressant effects of the medication.
C. Pain relief is the therapeutic effect of acetaminophen/hydrocodone, not an adverse effect.
D. Urinary retention can occur with opioid use due to their effects on the urinary sphincters and bladder muscle tone. Patients may experience difficulty urinating or incomplete emptying of the bladder.
E. Diarrhea is not a common adverse effect of acetaminophen/hydrocodone. In fact, opioids more commonly cause constipation rather than diarrhea.
Correct Answer is B
Explanation
A. Constricted pupils: Adrenergic agonist drugs typically cause pupil dilation (mydriasis), not constriction.
B. Increased heart rate: Adrenergic agonists stimulate the sympathetic nervous system, leading to increased heart rate (positive chronotropic effect) and increased cardiac contractility (positive
inotropic effect).
C. Bronchial constriction: Adrenergic agonists typically cause bronchodilation, not constriction.
D. Increased GI peristalsis: Adrenergic agonists usually inhibit GI motility, leading to decreased GI peristalsis and potentially constipation
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.